The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zakharov D.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Zakharova Iu.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Targets of rational neuroprotection in the therapy of chronic cerebral ischemia and the possibilities of achieving them

Authors:

Zakharov D.V., Zakharova Iu.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(8): 96‑101

DOI: 10.17116/jnevro202512508196

Read: 419 times

Buy for 300₽
Contact the author
Table of contents

TARGETS OF RATIONAL NEUROPROTECTION IN THE THERAPY OF CHRONIC CEREBRAL ISCHEMIA AND THE POSSIBILITIES OF ACHIEVING THEM
TARGETS OF RATIONAL NEUROPROTECTION IN THE THERAPY OF CHRONIC CEREBRAL ISCHEMIA AND THE POSSIBILITIES OF ACHIEVING THEM

To cite this article:

Zakharov DV, Zakharova IuV. Targets of rational neuroprotection in the therapy of chronic cerebral ischemia and the possibilities of achieving them. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;125(8):96‑101. (In Russ.)
https://doi.org/10.17116/jnevro202512508196

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
Evaluation of the effe­ctiveness of the drug Cortexin in combination with the use of the application Apha­sia.No (Afaziyam.Net) in the correction of speech diso­rders in patients with cere­bral infa­rction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):147-151
The effe­ctiveness of reha­bilitation measures using the drug Cortexin in children with neuropsychiatric pathology. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):86-92
Modern aspe­cts of chro­nic cere­bral ischemia pathogenetic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):106-113
Microcirculation in skin-fatty flaps of late­ral parts of the face and neck under application of hemo­static net. Plastic Surgery and Aesthetic Medi­cine. 2024;(4-2):52-57
Reso­lution of the expert council «Possibilities of neuroprotective therapy in patients with arte­rial hype­rtension and cognitive diso­rders». Russian Journal of Preventive Medi­cine. 2024;(11):85-93
Pulsatile versus non-pulsatile flow during cardiopulmonary bypass and its impact on microcirculation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):595-601
Effect of low-intensity laser-therapy in the correction of ence­phalopathy in obstructive jaundice. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):19-24
Neuroprotective therapy for age-related macu­lar dege­neration. Russian Annals of Ophthalmology. 2024;(6):152-158
Abstract:

Chronic cerebral ischemia (CCI) remains one of the leading causes of cognitive and neurological impairments that reduce the quality of life and work capacity of patients. Despite extensive research and development of pharmacology, effective neuroprotective approaches are still limited. The article reviews the key pathogenetic mechanisms of CCI: microcirculatory disorders, glutamate-mediated excitotoxicity, oxidative stress and neuroinflammation. The authors emphasize the need for target-oriented therapy capable of influencing various links of the ischemic cascade. Special attention is paid to the role of Cortexin, a peptide drug with proven neuroprotective effect. Its molecular mechanisms are discussed: normalization of glutamatergic transmission, antioxidant and anti-inflammatory action, restoration of blood-brain barrier. The results of experimental and clinical studies demonstrating the effectiveness of Cortexin in conditions of ischemic brain damage are presented. Biomarkers confirming the effect of Cortexin on the reduction of neurotoxicity (in particular, NR2-peptide concentration), enhancement of antioxidant activity and modulation of cytokine profile are analyzed separately. The article emphasizes the need to revise traditional concepts of neuroprotection in favor of pathogenesis-oriented, multitarget approaches. Cortexin is presented as a promising drug that meets modern requirements for rational neuroprotection in chronic cerebral ischemia.

Keywords:

chronic cerebral ischemia
microcirculation
neuroprotection
angioprotector
neuroinflammation
Cortexin

Authors:

Zakharov D.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Zakharova Iu.V.

V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology

Received:

01.07.2025

Accepted:

01.07.2025

Close metadata

References:

  1. Lee Reggie HC, Lee Michelle HH, Wu Celeste YC, et al. Cerebral ischemia and neuroregeneration. Neural Regen Res. 2018;13(3):373.  https://doi.org/10.4103/1673-5374.228711
  2. Lee RHC, Lee MHH, Wu CYC, et al. Corrigendum: Cerebral ischemia and neuroregeneration. Neural Regen Res. 2022;17(8):1639. https://doi.org/10.4103/1673-5374.332994
  3. Kadykov AS, Shakhparonova NV. Khronicheskie progressiruyushchie sosudistye zabolevaniya golovnogo mozga. Consilium medicum. Nevrologiya. 2003;(12):1-2. (In Russ.).
  4. Fedin PA, Lagoda OV, Dzhibladze DN, Gnezditskii VV. Kognitivnye vyzvannye potentsialy u bolnykh s ateroskleroticheskoi patologiei magistralnykh arterii golovy. Almanakh Klinicheskoi Meditsiny. 2006;(13):98-102. (In Russ.).
  5. Charway A, Koberskaya NN. The characteristics of the cognitive event related potential p300 in elderly patients with mild cognitive impairment associted with cerebrovascular insufficiency. Nevrologicheskii Zhurnal. 2006;11(S1):65-70. (In Russ.).
  6. Antonelli MC, Guillemin GJ, Raisman-Vozari R, et al. New Strategies in Neuroprotection and Neurorepair. Neurotox Res. 2012;21(1):49-56.  https://doi.org/10.1007/s12640-011-9265-8
  7. Zakharov DV, Mikhailov VA. Problems of cerebral microcirculation as a therapeutic target. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2016;(3):103-108. (In Russ.).
  8. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathol. 1969;12(1):1-15.  https://doi.org/10.1007/BF00685305
  9. Fisher CM. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol. 1971;30(3):536-550.  https://doi.org/10.1097/00005072-197107000-00015
  10. Moretti R, Caruso P. Small Vessel Disease: Ancient Description, Novel Biomarkers. Int J Mol Sci. 2022;23(7):3508. https://doi.org/10.3390/ijms23073508
  11. Nag S. Blood-brain barrier permeability using tracers and immunohistochemistry. Methods Mol Med. 2003;89:133-144.  https://doi.org/10.1385/1-59259-419-0:133
  12. Yang C, Hawkins KE, Doré S, Candelario-Jalil E. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol. 2019;316(2):C135-C153. https://doi.org/10.1152/ajpcell.00136.2018
  13. Schulte ML, Wood JD, Hudetz AG. Cortical electrical stimulation alters erythrocyte perfusion pattern in the cerebral capillary network of the rat. Brain Res. 2003;963(1-2):81-92.  https://doi.org/10.1016/S0006-8993(02)03848-9
  14. Villringer A, Them A, Lindauer U, et al. Capillary perfusion of the rat brain cortex. An in vivo confocal microscopy study. Circ Res. 1994;75(1):55-62.  https://doi.org/10.1161/01.RES.75.1.55
  15. Tarumi T, Zhang R. Cerebral blood flow in normal aging adults: cardiovascular determinants, clinical implications, and aerobic fitness. J Neurochem. 2018;144(5):595-608.  https://doi.org/10.1111/jnc.14234
  16. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology. 2008;55(3):310-318.  https://doi.org/10.1016/j.neuropharm.2008.01.005
  17. Puig B, Brenna S, Magnus T. Molecular Communication of a Dying Neuron in Stroke. Int J Mol Sci. 2018;19(9):2834. https://doi.org/10.3390/ijms19092834
  18. Payne SJ, Lucas C. Oxygen delivery from the cerebral microvasculature to tissue is governed by a single time constant of approximately 6 seconds. Microcirculation. 2018;25(2). https://doi.org/10.1111/micc.12428
  19. Du Y, Wang W, Lutton AD, et al. Dissipation of transmembrane potassium gradient is the main cause of cerebral ischemia-induced depolarization in astrocytes and neurons. Exp Neurol. 2018;303:1-11.  https://doi.org/10.1016/j.expneurol.2018.01.019
  20. Xue Y, Georgakopoulou T, van der Wijk AE, et al. Quantification of hypoxic regions distant from occlusions in cerebral penetrating arteriole trees. PLoS Comput Biol. 2022;18(8):e1010166. https://doi.org/10.1371/journal.pcbi.1010166
  21. Nadarajan V, Perry RJ, Johnson J, Werring DJ. Transient ischaemic attacks: mimics and chameleons. Pract Neurol. 2014;14(1):23-31.  https://doi.org/10.1136/practneurol-2013-000782
  22. Luoma JI, Kelley BG, Mermelstein PG. Progesterone inhibition of voltage-gated calcium channels is a potential neuroprotective mechanism against excitotoxicity. Steroids. 2011; 13(7): 34-39.  https://doi.org/10.1016/j.steroids.2011.02.013
  23. Papazian I, Kyrargyri V, Evangelidou M, et al. Mesenchymal stem cell protection of neurons against glutamate excitotoxicity involves reduction of NMDA-triggered calcium responses and surface GluR1, and is partly mediated by TNF. Int J Mol Sci. 2018;19(3): 23-28.  https://doi.org/10.3390/IJMS19030651
  24. Verma M, Wills Z, Chu CT. Excitatory dendritic mitochondrial calcium toxicity: Implications for Parkinson’s and other neurodegenerative diseases. Front Neurosci. 2018;12(AUG). https://doi.org/10.3389/FNINS.2018.00523
  25. Marmiroli P, Cavaletti G. The Glutamatergic Neurotransmission in the Central Nervous System. Curr Med Chem. 2012;19(9):1269-1276. https://doi.org/10.2174/092986712799462711
  26. Bylicky MA, Mueller GP, Day RM. Mechanisms of endogenous neuroprotective effects of astrocytes in brain injury. Oxid Med Cell Longev. 2018;2018. https://doi.org/10.1155/2018/6501031
  27. Volterra A, Trotti D, Tromba C, Floridi S, Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J Neurosc. 1994;14(5 I):2924-2932. https://doi.org/10.1523/jneurosci.14-05-02924.1994
  28. Harvey BK, Airavaara M, Hinzman J, et al. Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS One. 2011;6(8). https://doi.org/10.1371/JOURNAL.PONE.0022135
  29. Zhang LN, Hao L, Guo YS, et al. Are glutamate transporters neuroprotective or neurodegenerative during cerebral ischemia? J Mol Med. 2019;97(3):281-289.  https://doi.org/10.1007/S00109-019-01745-5
  30. Lewis DK, Thomas KT, Selvamani A, Sohrabji F. Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging. 2012;33(6):1123.e1-1123.e16.  https://doi.org/10.1016/j.neurobiolaging.2011.11.007
  31. Milewski K, Bogacińska-Karaś M, Hilgier W, et al. TNFα increases STAT3-mediated expression of glutaminase isoform KGA in cultured rat astrocytes. Cytokine. 2019;123.  https://doi.org/10.1016/j.cyto.2019.154774
  32. Olney JW. Brain Lesions, Obesity and Other Disturbances in Mice Treated with Monosodium Glutamate. Science (1979). 1969;164(3880):719-721.  https://doi.org/10.1126/science.164.3880.719
  33. Garthwaite G, Williams GD, Garthwaite J. Glutamate Toxicity: An Experimental and Theoretical Analysis. Eur J Neurosci. 1992;4(4):353-360.  https://doi.org/10.1111/j.1460-9568.1992.tb00882.x
  34. Choi D, Koh J, Peters S. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci. 1988;8(1):185-196.  https://doi.org/10.1523/JNEUROSCI.08-01-00185.1988
  35. Erecińska M, Silver IA. Tissue oxygen tension and brain sensitivity to hypoxia. Respir Physiol. 2001;128(3):263-276.  https://doi.org/10.1016/S0034-5687(01)00306-1
  36. Andrabi SS, Parvez S, Tabassum H. Ischemic stroke and mitochondria: mechanisms and targets. Protoplasma. 2020;257(2):335-343.  https://doi.org/10.1007/s00709-019-01439-2
  37. Sattler R, Xiong Z, Lu WY, et al. Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein. Science (1979). 1999;284(5421):1845-1848. https://doi.org/10.1126/SCIENCE.284.5421.1845
  38. Sugawara T, Noshita N, Lewen A, et al. Overexpression of copper/zinc superoxide dismutase in transgenic rats protects vulnerable neurons against ischemic damage by blocking the mitochondrial pathway of caspase activation. J Neurosci. 2002;22(1):209-217.  https://doi.org/10.1523/JNEUROSCI.22-01-00209.2002
  39. Kalogeris T, Bao Y, Korthuis RJ. Mitochondrial reactive oxygen species: A double edged sword in ischemia/reperfusion vs preconditioning. Redox Biol. 2014;2(1):702-714.  https://doi.org/10.1016/j.redox.2014.05.006
  40. Kudin AP, Augustynek B, Lehmann AK, et al. The contribution of thioredoxin-2 reductase and glutathione peroxidase to H2O2 detoxification of rat brain mitochondria. Biochim Biophys Acta Bioenerg. 2012;1817(10):1901-1906. https://doi.org/10.1016/j.bbabio.2012.02.023
  41. Simats A, García-Berrocoso T, Montaner J. Neuroinflammatory biomarkers: From stroke diagnosis and prognosis to therapy. Biochim Biophys Acta (BBA) — Mol Bas Dis. 2016;1862(3):411-424.  https://doi.org/10.1016/j.bbadis.2015.10.025
  42. Ramiro L, Simats A, García-Berrocoso T, Montaner J. Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management. Ther Adv Neurol Disord. 2018;11(7): 34-39.  https://doi.org/10.1177/1756286418789340
  43. Lucas S, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147(S1): 11-18.  https://doi.org/10.1038/sj.bjp.0706400
  44. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. J Transl Med. 2009;7(6): 34-37.  https://doi.org/10.1186/1479-5876-7-97
  45. Bustamante A, Simats A, Vilar-Bergua A, et al. Blood/Brain Biomarkers of Inflammation After Stroke and Their Association With Outcome: From C-Reactive Protein to Damage-Associated Molecular Patterns. Neurotherapeutics. 2016;13(4):671-684.  https://doi.org/10.1007/s13311-016-0470-2
  46. Hinzman JM, DiNapoli VA, Mahoney EJ, et al. Spreading depolarizations mediate excitotoxicity in the development of acute cortical lesions. Exp Neurol. 2015;267:243-253.  https://doi.org/10.1016/j.expneurol.2015.03.014
  47. Rakers C, Petzold GC. Astrocytic calcium release mediates peri-infarct depolarizations in a rodent stroke model. J Clin Invest. 2017;127(2):511-516.  https://doi.org/10.1172/JCI89354
  48. Piemonte F, Rossi F, Carletti B. Neuroprotection: The Emerging Concept of Restorative Neural Stem Cell Biology for the Treatment of Neurodegenerative Diseases. Curr Neuropharmacol. 2011;9(2):313-317.  https://doi.org/10.2174/157015911795596603
  49. Granstrem OK, Sorokina EG, Storozhevykh TP. Poslednie novosti o Korteksine (neiroprotektsiya na molekulyarnom urovne). Terra Medica Nova. 2008;5(55):40-44. (In Russ.).
  50. Gomazkov OA. Cortexin. Molecular mechanisms and targets of neuroprotective activity. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(8):99. (In Russ.). https://doi.org/10.17116/jnevro20151158199-104
  51. Kurkin DV, Morkovin EI, Kalatanova AV et al. Antioxidant effect of cortexin, cerebrolysin and actovegin in rats with chronic cerebrovascular insufficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(7):84-89. (In Russ.). https://doi.org/10.17116/jnevro202112107184
  52. Dolmans LS, Rutten FH, Koenen NCT, et al. Candidate Biomarkers for the Diagnosis of Transient Ischemic Attack: A Systematic Review. Cerebrovasc Dis. 2019;47(5-6):207-216.  https://doi.org/10.1159/000502449
  53. Dambinova SA, Aliev KT, Bondarenko E V, et al. The biomarkers of cerebral ischemia as a new method for the validation of the efficacy of cytoprotective therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(5):62-69.  https://doi.org/10.17116/jnevro20171175162-67
  54. Kurkin DV, Bakulin DA, Morkovin EI, et al. Neuroprotective action of Cortexin, Cerebrolysin and Actovegin in acute or chronic brain ischemia in rats. PLoS One. 2021;16(7):e0254493. https://doi.org/10.1371/journal.pone.0254493
  55. Fedin AI, Belskaya GN, Kurushina O V, et al. Dose-dependent effects of cortexin in chronic cerebral ischemia (results of a multicenter randomized controlled study). S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(9):35.( In Russ.). https://doi.org/10.17116/jnevro201811809135
  56. Stepanichev MYu, Onufriev MV, Peregud DI. Effects of cortexin on free radical oxidation and inflammatory processes in rats with normal and accelerated aging. Neurochemical Journal. 2018;35(2):187-198. (In Russ.). https://doi.org/10.7868/S1027813318020127
  57. Lkhasaranova IB, Pinelis YI. The impact of Cortexin on cytokine levels in the treatment of moderate chronic generalized periodontitis in young and middle-aged people. Parodontologiya. 2023;28(4):389-395.  https://doi.org/10.33925/1683-3759-2023-820
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.